Clinical Trial: A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232524) titled 'A Study of BL-M24D1 in Patients With Locally Advanced or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors' on Nov. 14.

Brief Summary: This study is an open, multicenter, non-randomized Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M24D1 in patients with locally advanced or metastatic head and neck squamous cell carcinoma and other solid tumors.

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Head and Neck Squamous Cell Carcinoma Solid Tumor

Intervention: DRUG: BL-M24D1

Administration by intravenous infusion...